NCT03817840View on ClinicalTrials.gov

Novel Mediators of the Lipodystrophy and Metabolic Consequences of Cushing's Disease

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

July 16, 2018

Primary Completion Date

July 1, 2021

Study Completion Date

July 1, 2021

Conditions
Cushing's Syndrome
Interventions
PROCEDURE

Treatment of Cushing's

Surgical resection of ACTH-secreting tumor to achieve cure of hypercortisolism

Trial Locations (1)

10032

Columbia University Neuroendocrine Unit, New York

All Listed Sponsors
collaborator

New York Obesity and Nutrition Research Center

OTHER

lead

Columbia University

OTHER

NCT03817840 - Novel Mediators of the Lipodystrophy and Metabolic Consequences of Cushing's Disease | Biotech Hunter | Biotech Hunter